EN IT

BMY — Bristol-Myers Squibb Company | Setup 20-24 Jul 2026

BMY
Bristol-Myers Squibb Company
Technical analysis updated on: 2026-07-25 · [ 20-24 Jul 2026 ] - Copyright AiTrading67.com
📅 Earnings · Jul 30, 2026 · in 5d
Stock · US
Inside composite NTZ, bullish bias · near monthly high
SCORE IQS Lite
86/100
Compressed phaseCompressed Ordinary phaseOrdinary Stretched phaseStretched Mature phaseMature
Weekly Structure 25
Daily Momentum 28
Weekly Ichimoku 17
Daily CMF 6
Delta 10
IQS Lite components · score
STRUCTURE25/30MOMENTUM28/35ICHIMOKU17/19CMF6/6DELTA10/10

IQS Lite analysis - AiTrading67.com · Bristol-Myers Squibb Company (BMY · ISIN US1101221083)

Weekly Structure
At 25/30 structure is very strong: full bullish alignment on the weekly.
Daily Momentum
At 28/35 momentum is strong: marked directional acceleration.
Weekly Ichimoku
At 17/19 Ichimoku is confirmed bullish: above the cloud with one of the two lines confirming.
Daily CMF
At 6/6 CMF shows inflows: capital entering and buying pressure.
Delta
At 10/10 the week is sharply up: weekly performance above +2%.
Concise reading of each axis score · sum = IQS Lite (0-100)
Executive View
Our view last week
Weekly structure maintains solid bullish alignment with free EMA50 and Ichimoku above cloud. Price consolidates within the neutral zone awaiting confirmed breakout trigger. Mature cycle phase suggests caution; await conviced directional signal.
This week's view by AiTrading67.com
The weekly structure remains favourable, with MACD in Strong bullish and EMA50 Free. Consolidation in the neutral zone requires caution: the cycle is already mature and daily momentum shows fading. Neutral rating.
Chart · 12-month trend
Charts provided by TradingView

Full in-depth analysis with precise levels and trade setup is reserved for ★ GOLD
Share WhatsApp Telegram Gmail LinkedIn